NorthWest Biotherapeutics Inc (NWBO)

[newman2021]

senti, interesting also to note is that Dr. Reardon is the PI of the Inovia's Phase1/2 CI combo results they are presenting at ASCO this time. Dr. Reardon still likes our DcVaxL as he understands when we combine DcVaxL with CI and TLR agonists, the combo destroys unmethylated hard to treat cancers too. Aren't we the emperors in the cancer world!! REGN is a partner in INO's trial; they have an TLR agonist too and they have Kevin Duffy now; What REGN doesn't have is DcVaxL. Well, going to be an epic war to snatch DcVaxL from MRK, imo. Is MRK going to announce something on June 7th premarket? Better I tell them.

https://finance.yahoo.com/news/inovio-announces-survival-results-ino-120000971.html